Imprimisrx

EyePoint Pharmaceuticals, Inc., based in Carlsbad, CA, is a leading developer of sustained-release drug delivery technologies aimed at treating eye diseases and chronic conditions. Their innovative solutions, such as Vorolanib and DURASERT, offer promising therapeutic options with a focus on enhancing patient outcomes and quality of life. Specializing in delivering first-in-class solutions, EyePoint's technologies have shown efficacy in clinical trials and have the potential to revolutionize treatment approaches for conditions like wet AMD. With a commitment to innovation and collaboration, EyePoint continues to expand its product portfolio and seek strategic partnerships to further advance the field of sustained-release drug delivery.Generated from the website